healthcare triangle, inc. (hti) reinforces healthcare progress through breakthrough technology and extensive industry know-how. we support healthcare providers and payors, hospitals and pharma/life sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility and accelerate responding to immediate business needs and competitive threats. the highly regulated healthcare and life sciences industries turn to hti for our expertise in digital transformation on the cloud, security and compliance, data lifecycle management, healthcare interoperability, clinical and business performance optimization. our headquarters is located in pleasanton, california and we have employees throughout the us.
Company profile
Ticker
HCTI
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Devcool, Inc. ...
IRS number
843559776
HCTI stock data
Latest filings (excl ownership)
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Mar 24
10-K
2023 FY
Annual report
18 Mar 24
8-K
Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO
18 Mar 24
EFFECT
Notice of effectiveness
14 Feb 24
CORRESP
Correspondence with SEC
13 Feb 24
S-1/A
IPO registration (amended)
12 Feb 24
S-1/A
IPO registration (amended)
9 Feb 24
CORRESP
Correspondence with SEC
9 Feb 24
8-K
Termination of a Material Definitive Agreement
2 Feb 24
8-K
Chairman of the Board
1 Feb 24
Latest ownership filings
4
Mohammad Jainal Bhuiyan
13 Mar 24
4
Ronald W. McClurg
13 Mar 24
4
David A Rosa
13 Mar 24
4
Shibu Kizhakevilayil
21 Mar 23
4
Thyagarajan Ramachandran
21 Mar 23
4
Anand Kumar
21 Mar 23
4
Lakshmanan Kannappan
21 Mar 23
3
Ronald W. McClurg
6 Feb 23
3
PAIGE HEAPHY
6 Feb 23
3
Mohammad Jainal Bhuiyan
6 Feb 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 75.00 k | 75.00 k | 75.00 k | 75.00 k | 75.00 k | 75.00 k |
Cash burn (monthly) | 19.00 k | 339.08 k | 646.33 k | 994.25 k | (no burn) | 421.17 k |
Cash used (since last report) | 125.89 k | 2.25 mm | 4.28 mm | 6.59 mm | n/a | 2.79 mm |
Cash remaining | -50.89 k | -2.17 mm | -4.21 mm | -6.51 mm | n/a | -2.72 mm |
Runway (months of cash) | -2.7 | -6.4 | -6.5 | -6.6 | n/a | -6.4 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 1 |
Closed positions | 5 |
Increased positions | 0 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 106.82 mm |
Total shares | 25.51 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Securekloud | 25.50 mm | $89.00 mm |
UBS UBS Group AG - Registered Shares | 4.57 k | $10.64 mm |
Tower Research Capital | 3.05 k | $7.10 mm |
FMR | 30.00 | $70.00 k |
BAC Bank Of America | 7.00 | $16.00 k |
Proequities | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Mar 24 | Mohammad Jainal Bhuiyan | Incentive Stock Option Common Stock | Grant | Acquire A | No | No | 1.78 | 5,000 | 8.90 k | 10,000 |
12 Mar 24 | Ronald W. McClurg | Incentive Stock Option Common Stock | Grant | Acquire A | No | No | 1.78 | 5,000 | 8.90 k | 10,000 |
12 Mar 24 | Rosa David A | Incentive Stock Option Common Stock | Grant | Acquire A | No | No | 1.78 | 10,000 | 17.80 k | 34,000 |
27 Apr 20 | Shibu Kizhakevilayil | Common Stock | Sale back to company | Acquire D | No | No | 0.001 | 200,000 | 200.00 | 200,000 |
27 Apr 20 | Anand Kumar | Common Stock | Sale back to company | Acquire D | No | No | 0.001 | 150,000 | 150.00 | 150,000 |
News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
11 Apr 24
12 Health Care Stocks Moving In Thursday's Pre-Market Session
4 Apr 24
Healthcare Triangle Appoints Anand Kumar As Interim CEO
12 Mar 24
12 Health Care Stocks Moving In Friday's After-Market Session
1 Mar 24
12 Health Care Stocks Moving In Friday's Intraday Session
16 Feb 24
Press releases
Healthcare Triangle Breaks New Ground in AI-Powered Patient Data Management with readabl.ai
3 Apr 24
Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
15 Mar 24
Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO
12 Mar 24
Empowering the Future of Healthcare: How Healthcare Triangle's AI Initiative Sets a New Standard in Patient Care Excellence
1 Mar 24
This Healthcare Frontrunner's AI Integration and Digital Transformation Drive is Revolutionizing Patient Care, Diagnostics and Treatment Outcomes on Global Scale: (Nasdaq: HCTI)
15 Feb 24